275 related articles for article (PubMed ID: 17255135)
21. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
Bernatsky S; Joseph L; Boivin JF; Gordon C; Urowitz M; Gladman D; Fortin PR; Ginzler E; Bae SC; Barr S; Edworthy S; Isenberg D; Rahman A; Petri M; Alarcón GS; Aranow C; Dooley MA; Rajan R; Sénécal JL; Zummer M; Manzi S; Ramsey-Goldman R; Clarke AE
Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
[TBL] [Abstract][Full Text] [Related]
22. A population-based assessment of systemic lupus erythematosus incidence and prevalence--results and implications of using administrative data for epidemiological studies.
Bernatsky S; Joseph L; Pineau CA; Tamblyn R; Feldman DE; Clarke AE
Rheumatology (Oxford); 2007 Dec; 46(12):1814-8. PubMed ID: 18032538
[TBL] [Abstract][Full Text] [Related]
23. Reproductive factors and risk of systemic lupus erythematosus: nationwide cohort study in Denmark.
Ulff-Møller CJ; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
J Rheumatol; 2009 Sep; 36(9):1903-9. PubMed ID: 19567628
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study.
Laustrup H; Voss A; Green A; Junker P
Scand J Rheumatol; 2009; 38(2):128-32. PubMed ID: 19117248
[TBL] [Abstract][Full Text] [Related]
25. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y
Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293
[TBL] [Abstract][Full Text] [Related]
26. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
Luminari S; Cesaretti M; Rashid I; Mammi C; Montanini A; Barbolini E; Bellei M; Pennese E; Sirotti MA; Marcheselli L; Partesotti G; Bari A; Maiorana A; Bonacorsi G; Federico M
Hematol Oncol; 2007 Dec; 25(4):189-97. PubMed ID: 17654762
[TBL] [Abstract][Full Text] [Related]
27. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset.
Romero-Díaz J; García-Sosa I; Sánchez-Guerrero J
J Rheumatol; 2009 Jan; 36(1):68-75. PubMed ID: 19012362
[TBL] [Abstract][Full Text] [Related]
28. Number of siblings and risk of Hodgkin's lymphoma.
Chang ET; Montgomery SM; Richiardi L; Ehlin A; Ekbom A; Lambe M
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1236-43. PubMed ID: 15247136
[TBL] [Abstract][Full Text] [Related]
29. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
30. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
[TBL] [Abstract][Full Text] [Related]
31. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.
Björnådal L; Löfström B; Yin L; Lundberg IE; Ekbom A
Scand J Rheumatol; 2002; 31(2):66-71. PubMed ID: 12109649
[TBL] [Abstract][Full Text] [Related]
32. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
34. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; Béron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
[TBL] [Abstract][Full Text] [Related]
35. Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Gobbi PG; Angrilli F; Brugiatelli M; Musto P; Federico M
Haematologica; 2008 Sep; 93(9):1335-42. PubMed ID: 18698083
[TBL] [Abstract][Full Text] [Related]
36. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006.
Mok CC; To CH; Ho LY; Yu KL
J Rheumatol; 2008 Oct; 35(10):1978-82. PubMed ID: 18688913
[TBL] [Abstract][Full Text] [Related]
37. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort.
Burling F; Ng J; Thein H; Ly J; Marshall MR; Gow P
Lupus; 2007; 16(10):830-7. PubMed ID: 17895308
[TBL] [Abstract][Full Text] [Related]
38. Systemic lupus erythematosus and the risk of malignancy.
Cibere J; Sibley J; Haga M
Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients.
Hernández-Salazar A; Rosales SP; Rangel-Frausto S; Criollo E; Archer-Dubon C; Orozco-Topete R
Arch Med Res; 2006 Oct; 37(7):899-902. PubMed ID: 16971233
[TBL] [Abstract][Full Text] [Related]
40. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study.
Monnereau A; Orsi L; Troussard X; Berthou C; Fenaux P; Soubeyran P; Marit G; Huguet F; Milpied N; Leporrier M; Hemon D; Clavel J
Cancer Causes Control; 2008 Dec; 19(10):1147-60. PubMed ID: 18781390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
